EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Epigenetic reprogramming in tuberculosis: mechanisms of immune evasion and host-directed therapies

Xinran Ding, Chenyan Zhou, Jiahai Shi, Yongwei Qin

Biochemical Pharmacology · 2026

DOI: 10.1016/j.bcp.2026.118010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochemical Pharmacology, 2026. Verfasst von Xinran Ding und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathogen Biology, Medical College, Nantong University, Nantong 226001, China. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Mycobacterium tuberculosis, Tuberculosis, Immune Evasion. Die Arbeit nennt 205 Literaturangaben. Gefördert von: Nantong University, Jiangsu Province Postdoctoral Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycobacterium tuberculosis (Mtb) evades host immunity by actively reprogramming host gene expression, which allows the pathogen to persist within immune cells. Recent high-throughput sequencing and epigenomic studies have shown that Mtb reshapes the host epigenetic landscape by altering DNA methylation, histone modifications (including acetylation and methylation), and non-coding RNA networks. These modifications impact immune transcriptional programs and create an intracellular environment that favors bacterial survival. Importantly, these reversible epigenetic signatures offer promising pharmacological targets. This review systematically explores the immunological consequences of host epigenetic regulation during Mtb infection, evaluates the mechanisms of trained immunity, and highlights the therapeutic potential of pharmacological epigenetic modulators, such as inhibitors of histone deacetylases, DNA methyltransferases, and miRNA modulators. Furthermore, it discusses the development of emerging druggable targets, including novel epigenetic modifiers and immunometabolic hubs, while emphasizing the potential synergy of combining these epigenetic host-directed therapies with conventional antibiotics for treating tuberculosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epigenesis, GeneticMycobacterium tuberculosisTuberculosisImmune EvasionAntitubercular AgentsHumansHost-Directed TherapyAnimalsHost-Pathogen InteractionsDNA MethylationTrained Immunity

Stichwörter der Autor:innen

Bacillus Calmette-Guérin-induced trained immunityEmerging druggable targetEpigenetic therapeuticsHost-directed therapyImmunometabolismMycobacterium tuberculosis

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Department of Pathogen Biology, Medical College, Nantong University, Nantong 226001, China.
  • Nantong Key Laboratory of Translational Medicine in Cardiothoracic Diseases, Nantong Clinical Medical Research Center of Cardiothoracic Disease, and Institution of Translational Medicine in Cardiothoracic Diseases, Affi…
  • Department of Pathogen Biology, Medical College, Nantong University, Nantong 226001, China. Electronic address: yw_qin@ntu.edu.cn.

Förderung

  • Nantong University
  • Jiangsu Province Postdoctoral Science Foundation
  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • Jiangsu Postdoctoral Research Foundation
  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Ding, X., Zhou, C., Shi, J., & Qin, Y. (2026). Epigenetic reprogramming in tuberculosis: mechanisms of immune evasion and host-directed therapies. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2026.118010

Vancouver

Ding X, Zhou C, Shi J, Qin Y. Epigenetic reprogramming in tuberculosis: mechanisms of immune evasion and host-directed therapies. Biochemical Pharmacology. 2026. doi:10.1016/j.bcp.2026.118010

BibTeX
@article{Ding2026,
  author = {Ding, Xinran and Zhou, Chenyan and Shi, Jiahai and Qin, Yongwei},
  title = {Epigenetic reprogramming in tuberculosis: mechanisms of immune evasion and host-directed therapies},
  journal = {Biochemical Pharmacology},
  year = {2026},
  doi = {10.1016/j.bcp.2026.118010}
}
Kostenlos starten →